NYLIM
CDMO

New York Life Investment Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

New York Life Investment Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-161,849
Closed -$2M – 867
2024
Q4 		$2M Buy
+161,849
New +$1.85M 0.02% 552

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

New York Life Investment Management's CDMO Position: Q1 2025 in Review

New York Life Investment Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 161,849 shares — an estimated $2M sold.

New York Life Investment Management first reported a position in CDMO in Q4 2024 and held it in 1 quarter. The position peaked at $2M in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • New York Life Investment Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • New York Life Investment Management sold 161,849 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $2M.
  • New York Life Investment Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
  • New York Life Investment Management's Avid Bioservices, Inc. Common Stock position peaked at $2M in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on New York Life Investment Management's 13F filing for Q1 2025, filed 8 May 2025.